{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:31Z","timestamp":1792782631544,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Huifang Tang","award":["81570056"],"award-info":[{"award-number":["81570056"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00408-025-00787-6","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T14:22:56Z","timestamp":1739715776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PDE4B Modulates Phosphorylation of p65 (Ser468) via cAMP\/PKA in Acute Lung Injury"],"prefix":"10.1007","volume":"203","author":[{"given":"Rana","family":"Dhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunde","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhewen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"issue":"Suppl 1","key":"787_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1513\/AnnalsATS.201407-340MG","volume":"12","author":"V Fanelli","year":"2015","unstructured":"Fanelli V, Ranieri VM (2015) Mechanisms and clinical consequences of acute lung injury. Ann Am Thorac Soc 12(Suppl 1):S3\u2013S8","journal-title":"Ann Am Thorac Soc"},{"key":"787_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","volume":"140","author":"Y Butt","year":"2016","unstructured":"Butt Y, Kurdowska A, Allen TC (2016) Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med 140:345\u2013350","journal-title":"Arch Pathol Lab Med"},{"key":"787_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249038","volume":"16","author":"E Oliveira","year":"2021","unstructured":"Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, Fernainy K, Andersen S, Mercado L, Guan J, Zafar H, Louzon P, Carr A, Baloch N, Pratley R, Silverstry S, Hsu V, Sniffen J, Herrera V, Finkler N (2021) ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS ONE 16:e0249038","journal-title":"PLoS ONE"},{"key":"787_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1586\/ers.10.71","volume":"4","author":"H Chen","year":"2010","unstructured":"Chen H, Bai C, Wang X (2010) The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med 4:773\u2013783","journal-title":"Expert Rev Respir Med"},{"key":"787_CR5","doi-asserted-by":"publisher","first-page":"705080","DOI":"10.3389\/fimmu.2021.705080","volume":"12","author":"KA Shirey","year":"2021","unstructured":"Shirey KA, Blanco JCG, Vogel SN (2021) Targeting TLR4 signaling to blunt viral-mediated acute lung injury. Front Immunol 12:705080","journal-title":"Front Immunol"},{"key":"787_CR6","doi-asserted-by":"publisher","first-page":"109568","DOI":"10.1016\/j.cbi.2021.109568","volume":"345","author":"K Alharbi","year":"2021","unstructured":"Alharbi K, Fuloria N, Fuloria S, Rahman S, Al-Malki W, Javed Shaikh M, Thangavelu L, Singh S, Rama Raju Allam V, Jha N, Chellappan D, Dua K, Gupta G (2021) Nuclear factor-kappa B and its role in inflammatory lung disease. Chem-Biol Interact 345:109568","journal-title":"Chem-Biol Interact"},{"key":"787_CR7","doi-asserted-by":"publisher","first-page":"716469","DOI":"10.3389\/fimmu.2021.716469","volume":"12","author":"L Barnabei","year":"2021","unstructured":"Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R (2021) NF-\u03baB: at the borders of autoimmunity and inflammation. Front Immunol 12:716469","journal-title":"Front Immunol"},{"key":"787_CR8","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1111\/odi.12275","volume":"21","author":"F Ahmad","year":"2015","unstructured":"Ahmad F, Murata T, Shimizu K, Degerman E, Maurice D, Manganiello V (2015) Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets. Oral Dis 21:e25\u2013e50","journal-title":"Oral Dis"},{"key":"787_CR9","first-page":"353","volume":"43","author":"SD Song","year":"2014","unstructured":"Song SD, Tang HF (2014) Progress in PDE4 targeted therapy for inflammatory diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban 43:353\u2013358","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"787_CR10","doi-asserted-by":"publisher","first-page":"e31574","DOI":"10.1371\/journal.pone.0031574","volume":"7","author":"A Oldenburger","year":"2012","unstructured":"Oldenburger A, Roscioni SS, Jansen E, Menzen MH, Halayko AJ, Timens W, Meurs H, Maarsingh H, Schmidt M (2012) Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease. PLoS ONE 7:e31574","journal-title":"PLoS ONE"},{"key":"787_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/1381612820666140826114412","volume":"21","author":"RT Wen","year":"2015","unstructured":"Wen RT, Feng WY, Liang JH, Zhang HT (2015) Role of phosphodiesterase 4-mediated cyclic AMP signaling in pharmacotherapy for substance dependence. Curr Pharm Des 21:355\u2013364","journal-title":"Curr Pharm Des"},{"key":"787_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/14656566.2019.1570132","volume":"20","author":"D Al-Sajee","year":"2019","unstructured":"Al-Sajee D, Yin X, Gauvreau GM (2019) An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma. Expert Opin Pharmacother 20:609\u2013620","journal-title":"Expert Opin Pharmacother"},{"key":"787_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2020.00259","volume":"11","author":"JE Phillips","year":"2020","unstructured":"Phillips JE (2020) Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases. Front Pharmacol 11:259","journal-title":"Front Pharmacol"},{"key":"787_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/0929867323666151117121334","volume":"23","author":"N Parikh","year":"2016","unstructured":"Parikh N, Chakraborti AK (2016) Phosphodiesterase 4 (PDE4) inhibitors in the treatment of COPD: promising drug candidates and future directions. Curr Med Chem 23:129\u2013141","journal-title":"Curr Med Chem"},{"key":"787_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1517\/14656566.2015.1034107","volume":"16","author":"H Abdulrahim","year":"2015","unstructured":"Abdulrahim H, Thistleton S, Adebajo AO, Shaw T, Edwards C, Wells A (2015) Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis. Expert Opin Pharmacother 16:1099\u20131108","journal-title":"Expert Opin Pharmacother"},{"key":"787_CR16","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3390\/ijms18061276","volume":"18","author":"M Spadaccini","year":"2017","unstructured":"Spadaccini M, D\u2019Alessio S, Peyrin-Biroulet L, Danese S (2017) PDE4 inhibition and inflammatory bowel disease: a novel therapeutic avenue. Int J Mol Sci 18:1276","journal-title":"Int J Mol Sci"},{"key":"787_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cellsig.2015.09.019","volume":"28","author":"NJ Brandon","year":"2016","unstructured":"Brandon NJ (2016) Uncovering the function of disrupted in Schizophrenia 1 through interactions with the cAMP phosphodiesterase PDE4: contributions of the Houslay lab to molecular psychiatry. Cell Signal 28:749\u2013752","journal-title":"Cell Signal"},{"key":"787_CR18","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1186\/cc7158","volume":"12","author":"A Link","year":"2008","unstructured":"Link A, Selejan S, Maack C, Lenz M, Bohm M (2008) Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock. Crit Care 12:R159","journal-title":"Crit Care"},{"key":"787_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1165\/ajrcmb.18.3.2913","volume":"18","author":"JM Miotla","year":"1998","unstructured":"Miotla JM, Teixeira MM, Hellewell PG (1998) Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Am J Respir Cell Mol Biol 18:411\u2013420","journal-title":"Am J Respir Cell Mol Biol"},{"key":"787_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejphar.2011.02.042","volume":"659","author":"S Kubo","year":"2011","unstructured":"Kubo S, Kobayashi M, Iwata M, Takahashi K, Miyata K, Shimizu Y (2011) Disease-modifying effect of ASP3258, a novel phosphodiesterase type 4 inhibitor, on subchronic cigarette smoke exposure-induced lung injury in guinea pigs. Eur J Pharmacol 659:79\u201384","journal-title":"Eur J Pharmacol"},{"key":"787_CR21","doi-asserted-by":"publisher","first-page":"L56","DOI":"10.1152\/ajplung.00041.2011","volume":"302","author":"YP de Visser","year":"2012","unstructured":"de Visser YP, Walther FJ, el Laghmani H, Steendijk P, Middeldorp M, van der Laarse A, Wagenaar GT (2012) Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 302:L56-67","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"787_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.intimp.2010.01.003","volume":"10","author":"HF Tang","year":"2010","unstructured":"Tang HF, Lu JJ, Tang JF, Zheng X, Liang YQ, Wang XF, Wang YJ, Mao LG, Chen JQ (2010) Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury. Int Immunopharmacol 10:406\u2013411","journal-title":"Int Immunopharmacol"},{"key":"787_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1472-8206.1999.tb00326.x","volume":"13","author":"N Escofier","year":"1999","unstructured":"Escofier N, Boichot E, Germain N, Silva PM, Martins MA, Lagente V (1999) Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung. Fundam Clin Pharmacol 13:96\u2013101","journal-title":"Fundam Clin Pharmacol"},{"key":"787_CR24","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/emi.2013.52","volume":"2","author":"G Sharma","year":"2013","unstructured":"Sharma G, Champalal Sharma D, Hwei Fen L, Pathak M, Bethur N, Pendharkar V, Peiris M, Altmeyer R (2013) Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor. Emerg Microbes Infect 2:e54","journal-title":"Emerg Microbes Infect"},{"key":"787_CR25","doi-asserted-by":"publisher","first-page":"114431","DOI":"10.1016\/j.bcp.2021.114431","volume":"185","author":"C Lugnier","year":"2021","unstructured":"Lugnier C, Al-Kuraishy HM, Rousseau E (2021) PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol 185:114431","journal-title":"Biochem Pharmacol"},{"key":"787_CR26","first-page":"335","volume":"22","author":"C Bridgewood","year":"2020","unstructured":"Bridgewood C, Damiani G, Sharif K, Watad A, Bragazzi NL, Quartuccio L, Savic S, McGonagle D (2020) Rationale for evaluating PDE4 inhibition for mitigating against severe inflammation in COVID-19 pneumonia and beyond. Isr Med Assoc J 22:335\u2013339","journal-title":"Isr Med Assoc J"},{"key":"787_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/acph-2015-0016","volume":"65","author":"O Suzuki","year":"2015","unstructured":"Suzuki O, Goto T, Yoshino T, Nakamura S, Maeda H (2015) The role of phosphodiesterase 4B in IL-8\/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor. Acta Pharm 65:191\u2013197","journal-title":"Acta Pharm"},{"key":"787_CR28","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.4049\/jimmunol.173.12.7531","volume":"173","author":"M Ariga","year":"2004","unstructured":"Ariga M, Neitzert B, Nakae S, Mottin G, Bertrand C, Pruniaux MP, Jin SL, Conti M (2004) Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation. J Immunol 173:7531\u20137538","journal-title":"J Immunol"},{"key":"787_CR29","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","volume":"175","author":"SL Jin","year":"2005","unstructured":"Jin SL, Lan L, Zoudilova M, Conti M (2005) Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J Immunol 175:1523\u20131531","journal-title":"J Immunol"},{"key":"787_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0026-895X(24)26397-5","volume":"56","author":"P Wang","year":"1999","unstructured":"Wang P, Wu P, Ohleth KM, Egan RW, Billah MM (1999) Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol 56:170\u2013174","journal-title":"Mol Pharmacol"},{"key":"787_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cellsig.2007.12.011","volume":"20","author":"HJ Kwak","year":"2008","unstructured":"Kwak HJ, Park KM, Choi HE, Chung KS, Lim HJ, Park HY (2008) PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways. Cell Signal 20:803\u2013814","journal-title":"Cell Signal"},{"key":"787_CR32","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.4049\/jimmunol.1400942","volume":"193","author":"H Tang","year":"2014","unstructured":"Tang H, Liu Y, Yan C, Petasis N, Serhan C, Gao H (2014) Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. J Immunol 193:3769\u20133778","journal-title":"J Immunol"},{"key":"787_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1165\/rcmb.2021-0531ST","volume":"66","author":"HS Kulkarni","year":"2022","unstructured":"Kulkarni HS, Lee JS, Bastarache JA, Kuebler WM, Downey GP, Albaiceta GM, Altemeier WA, Artigas A, Bates JHT, Calfee CS, Dela Cruz CS, Dickson RP, Englert JA, Everitt JI, Fessler MB, Gelman AE, Gowdy KM, Groshong SD, Herold S, Homer RJ, Horowitz JC, Hsia CCW, Kurahashi K, Laubach VE, Looney MR, Lucas R, Mangalmurti NS, Manicone AM, Martin TR, Matalon S, Matthay MA, McAuley DF, McGrath-Morrow SA, Mizgerd JP, Montgomery SA, Moore BB, No\u00ebl A, Perlman CE, Reilly JP, Schmidt EP, Skerrett SJ, Suber TL, Summers C, Suratt BT, Takata M, Tuder R, Uhlig S, Witzenrath M, Zemans RL, Matute-Bello G (2022) Update on the features and measurements of experimental acute lung injury in animals: an official American Thoracic Society Workshop Report. Am J Respir Cell Mol Biol 66:e1\u2013e14","journal-title":"Am J Respir Cell Mol Biol"},{"key":"787_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM (2011) An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44:725\u2013738","journal-title":"Am J Respir Cell Mol Biol"},{"key":"787_CR35","first-page":"e52749","volume":"98","author":"A Layoun","year":"2015","unstructured":"Layoun A, Samba M, Santos MM (2015) Isolation of murine peritoneal macrophages to carry out gene expression analysis upon Toll-like receptors stimulation. J Vis Exp 98:e52749","journal-title":"J Vis Exp"},{"key":"787_CR36","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1084\/jem.142.5.1150","volume":"142","author":"PJ Edelson","year":"1975","unstructured":"Edelson PJ, Zwiebel R, Cohn ZA (1975) The pinocytic rate of activated macrophages. J Exp Med 142:1150\u20131164","journal-title":"J Exp Med"},{"key":"787_CR37","doi-asserted-by":"publisher","first-page":"e1631","DOI":"10.21769\/BioProtoc.1631","volume":"5","author":"X Liu","year":"2015","unstructured":"Liu X, Quan N (2015) Immune cell isolation from mouse femur bone marrow. Bio Protoc 5:e1631","journal-title":"Bio Protoc"},{"key":"787_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jlb.41.1.83","volume":"41","author":"G Boltz-Nitulescu","year":"1987","unstructured":"Boltz-Nitulescu G, Wiltschke C, Holzinger C, Fellinger A, Scheiner O, Gessl A, F\u00f6rster O (1987) Differentiation of rat bone marrow cells into macrophages under the influence of mouse L929 cell supernatant. J Leukoc Biol 41:83\u201391","journal-title":"J Leukoc Biol"},{"key":"787_CR39","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1073\/pnas.122041599","volume":"99","author":"SL Jin","year":"2002","unstructured":"Jin SL, Conti M (2002) Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci USA 99:7628\u20137633","journal-title":"Proc Natl Acad Sci USA"},{"key":"787_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0076-6879(91)00127-I","volume":"200","author":"RB Pearson","year":"1991","unstructured":"Pearson RB, Kemp BE (1991) Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol 200:62\u201381","journal-title":"Methods Enzymol"},{"key":"787_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1128\/IAI.00939-07","volume":"76","author":"RS Munford","year":"2008","unstructured":"Munford RS (2008) Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun 76:454\u2013465","journal-title":"Infect Immun"},{"key":"787_CR42","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10753-018-0761-3","volume":"41","author":"XF Wang","year":"2018","unstructured":"Wang XF, Song SD, Li YJ, Hu ZQ, Zhang ZW, Yan CG, Li ZG, Tang HF (2018) Protective effect of quercetin in LPS-induced murine acute lung injury mediated by cAMP-Epac pathway. Inflammation 41:1093\u20131103","journal-title":"Inflammation"},{"key":"787_CR43","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jaci.2010.08.014","volume":"126","author":"SL Jin","year":"2010","unstructured":"Jin SL, Goya S, Nakae S, Wang D, Bruss M, Hou C, Umetsu D, Conti M (2010) Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 126:1252-1259.e12","journal-title":"J Allergy Clin Immunol"},{"key":"787_CR44","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.bbrc.2014.07.024","volume":"450","author":"H Ma","year":"2014","unstructured":"Ma H, Shi J, Wang C, Guo L, Gong Y, Li J, Gong Y, Yun F, Zhao H, Li E (2014) Blockade of PDE4B limits lung vascular permeability and lung inflammation in LPS-induced acute lung injury. Biochem Biophys Res Commun 450:1560\u20131567","journal-title":"Biochem Biophys Res Commun"},{"key":"787_CR45","doi-asserted-by":"publisher","first-page":"46165","DOI":"10.1038\/srep46165","volume":"7","author":"JX Yang","year":"2017","unstructured":"Yang JX, Hsieh KC, Chen YL, Lee CK, Conti M, Chuang TH, Wu CP, Jin SC (2017) Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages. Sci Rep 7:46165","journal-title":"Sci Rep"},{"key":"787_CR46","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s10753-018-0819-2","volume":"41","author":"Y Zhuo","year":"2018","unstructured":"Zhuo Y, Zhang S, Li C, Yang L, Gao H, Wang X (2018) Resolvin D1 promotes SIRT1 expression to counteract the activation of STAT3 and NF-kappaB in mice with septic-associated lung injury. Inflammation 41:1762\u20131771","journal-title":"Inflammation"},{"key":"787_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1165\/rcmb.2016-0390OC","volume":"58","author":"C Gross","year":"2018","unstructured":"Gross C, Kellner M, Wang T, Lu Q, Sun X, Zemskov E, Noonepalle S, Kangath A, Kumar S, Gonzalez-Garay M, Desai A, Aggarwal S, Gorshkov B, Klinger C, Verin A, Catravas J, Jacobson J, Yuan J, Rafikov R, Garcia J, Black S (2018) LPS-induced acute lung injury involves NF-\u03baB-mediated downregulation of SOX18. Am J Respir Cell Mol Biol 58:614\u2013624","journal-title":"Am J Respir Cell Mol Biol"},{"key":"787_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ejps.2011.09.020","volume":"44","author":"B Zhang","year":"2011","unstructured":"Zhang B, Liu Z, Li Y, Luo Y, Liu M, Dong H, Wang Y, Liu Y, Zhao P, Jin F, Li Z (2011) Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci 44:573\u2013579","journal-title":"Eur J Pharm Sci"},{"key":"787_CR49","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.pharep.2018.03.009","volume":"70","author":"F Imam","year":"2018","unstructured":"Imam F, Al-Harbi N, Al-Harbi M, Ansari M, Al-Asmari A, Ansari M, Al-Anazi W, Bahashwan S, Almutairi M, Alshammari M, Khan M, Alsaad A, Alotaibi M (2018) Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-\u03baB signaling pathways. Pharmacol Rep 70:993\u20131000","journal-title":"Pharmacol Rep"},{"key":"787_CR50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","volume":"9","author":"RS Wallis","year":"2021","unstructured":"Wallis RS, Ginindza S, Beattie T, Arjun N, Likoti M, Edward VA, Rassool M, Ahmed K, Fielding K, Ahidjo BA, Vangu MDT, Churchyard G (2021) Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med 9:897\u2013908","journal-title":"Lancet Respir Med"},{"key":"787_CR51","doi-asserted-by":"publisher","first-page":"1270414","DOI":"10.3389\/fimmu.2023.1270414","volume":"14","author":"A Kolloli","year":"2023","unstructured":"Kolloli A, Ramasamy S, Kumar R, Nisa A, Kaplan G, Subbian S (2023) A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection. Front Immunol 14:1270414","journal-title":"Front Immunol"},{"key":"787_CR52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1513\/pats.201001-002SM","volume":"7","author":"G Hoyle","year":"2010","unstructured":"Hoyle G (2010) Mitigation of chlorine lung injury by increasing cyclic AMP levels. Proc Am Thorac Soc 7:284\u2013289","journal-title":"Proc Am Thorac Soc"},{"key":"787_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0162-3109(00)00185-5","volume":"47","author":"J Souness","year":"2000","unstructured":"Souness J, Aldous D, Sargent C (2000) Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 47:127\u2013162","journal-title":"Immunopharmacology"},{"key":"787_CR54","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/molecules24213875","volume":"24","author":"M Chen","year":"2019","unstructured":"Chen M, Cui Y, Li H, Luan J, Zhou X, Han J (2019) Icariin promotes the osteogenic action of BMP2 by activating the cAMP signaling pathway. Molecules 24:3875","journal-title":"Molecules"},{"key":"787_CR55","doi-asserted-by":"publisher","first-page":"e0136311","DOI":"10.1371\/journal.pone.0136311","volume":"10","author":"S Terazawa","year":"2015","unstructured":"Terazawa S, Mori S, Nakajima H, Yasuda M, Imokawa G (2015) The UVB-stimulated expression of transglutaminase 1 is mediated predominantly via the NFkappaB signaling pathway: new evidence of its significant attenuation through the specific interruption of the p38\/MSK1\/NFkappaBp65 Ser276 axis. PLoS ONE 10:e0136311","journal-title":"PLoS ONE"},{"key":"787_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0898-6568(93)90019-I","volume":"5","author":"M Muroi","year":"1993","unstructured":"Muroi M, Suzuki T (1993) Role of protein kinase A in LPS-induced activation of NF-kappa B proteins of a mouse macrophage-like cell line, J774. Cell Signal 5:289\u2013298","journal-title":"Cell Signal"},{"key":"787_CR57","doi-asserted-by":"publisher","first-page":"e49512","DOI":"10.1371\/journal.pone.0049512","volume":"7","author":"LL Reber","year":"2012","unstructured":"Reber LL, Daubeuf F, Nemska S, Frossard N (2012) The AGC kinase inhibitor H89 attenuates airway inflammation in mouse models of asthma. PLoS ONE 7:e49512","journal-title":"PLoS ONE"},{"key":"787_CR58","doi-asserted-by":"publisher","first-page":"e4393","DOI":"10.1371\/journal.pone.0004393","volume":"4","author":"L Reber","year":"2009","unstructured":"Reber L, Vermeulen L, Haegeman G, Frossard N (2009) Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS ONE 4:e4393","journal-title":"PLoS ONE"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-025-00787-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:02:07Z","timestamp":1766379727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-025-00787-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["787"],"URL":"https:\/\/doi.org\/10.1007\/s00408-025-00787-6","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation for Drl Yajun Li has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"33"}}